HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Takaaki Arigami Selected Research
Takaaki Arigami Research Topics
Disease
86
Neoplasms (Cancer)
03/2024 - 05/2004
78
Stomach Neoplasms (Stomach Cancer)
03/2024 - 01/2007
32
Neoplasm Metastasis (Metastasis)
03/2024 - 03/2006
21
Lymphatic Metastasis
03/2024 - 04/2008
16
Esophageal Neoplasms (Esophageal Cancer)
10/2023 - 10/2006
13
Esophageal Squamous Cell Carcinoma
08/2022 - 03/2011
11
Adenocarcinoma
01/2022 - 06/2012
9
Pancreatic Neoplasms (Pancreatic Cancer)
07/2022 - 02/2012
6
Breast Neoplasms (Breast Cancer)
01/2019 - 01/2008
6
Neoplasm Micrometastasis
01/2018 - 06/2008
5
Circulating Neoplastic Cells
01/2021 - 01/2017
4
Pathologic Constriction (Stenosis)
10/2023 - 10/2013
4
Rectal Neoplasms (Rectal Cancer)
08/2023 - 04/2018
4
Colorectal Neoplasms (Colorectal Cancer)
07/2023 - 04/2018
3
Anastomotic Leak
10/2023 - 12/2017
3
Colonic Neoplasms (Colon Cancer)
04/2020 - 01/2015
3
Sepsis (Septicemia)
10/2019 - 06/2013
3
Melanoma (Melanoma, Malignant)
02/2010 - 06/2008
2
Wounds and Injuries (Trauma)
11/2022 - 10/2019
2
Carcinoma (Carcinomatosis)
01/2021 - 03/2012
2
Residual Neoplasm
07/2020 - 07/2010
2
Infections
01/2019 - 10/2015
2
Disseminated Intravascular Coagulation
12/2017 - 10/2015
2
Hypoalbuminemia
12/2016 - 10/2015
2
Malnutrition (Nutritional Deficiencies)
10/2015 - 05/2010
2
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
10/2013 - 10/2006
1
Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
01/2023
1
Mediastinal Emphysema (Pneumomediastinum)
12/2022
1
Cholangiocarcinoma
07/2022
1
Microsatellite Instability
06/2022
Drug/Important Bio-Agent (IBA)
10
Paclitaxel (Taxol)
FDA Link
Generic
11/2023 - 01/2007
10
Messenger RNA (mRNA)
IBA
04/2018 - 06/2008
8
Cisplatin (Platino)
FDA Link
Generic
11/2023 - 04/2015
7
Trastuzumab (Herceptin)
FDA Link
03/2024 - 12/2018
6
Immune Checkpoint Inhibitors
IBA
07/2022 - 03/2018
6
Carbohydrates
IBA
07/2022 - 01/2012
6
Antigens
IBA
11/2021 - 01/2012
6
Proteins (Proteins, Gene)
FDA Link
01/2019 - 11/2008
6
Radioisotopes (Radionuclides)
IBA
09/2018 - 05/2004
6
Colloids (Colloid)
IBA
09/2013 - 05/2004
5
Docetaxel (Taxotere)
FDA Link
08/2022 - 06/2013
5
MicroRNAs (MicroRNA)
IBA
10/2021 - 08/2017
5
Fibrinogen (Factor I)
FDA Link
02/2017 - 10/2015
5
Hematoxylin (Haematoxylon)
IBA
02/2016 - 03/2006
5
Eosine Yellowish-(YS) (Eosin)
IBA
02/2016 - 03/2006
4
human ERBB2 protein
IBA
03/2024 - 01/2020
4
Bevacizumab (Avastin)
FDA Link
07/2023 - 03/2020
4
Fluorouracil (Carac)
FDA Link
Generic
08/2022 - 04/2015
4
Oxaliplatin (Eloxatin)
FDA Link
Generic
01/2022 - 03/2019
4
Nivolumab
IBA
04/2021 - 01/2020
4
Biomarkers (Surrogate Marker)
IBA
10/2020 - 02/2010
4
Therapeutic Uses
IBA
03/2020 - 11/2015
4
Carcinoembryonic Antigen
IBA
02/2018 - 08/2008
4
HLA Antigens (Human Leukocyte Antigens)
IBA
11/2015 - 10/2012
3
Ramucirumab
IBA
06/2022 - 07/2020
3
C-Reactive Protein
IBA
01/2021 - 10/2015
3
RNA (Ribonucleic Acid)
IBA
08/2020 - 11/2008
3
Paraffin
IBA
07/2020 - 06/2008
3
Coloring Agents (Dyes)
IBA
09/2017 - 05/2004
2
ErbB Receptors (EGF Receptor)
IBA
12/2022 - 04/2022
2
CA-19-9 Antigen (CA 19-9 Antigen)
IBA
07/2022 - 11/2016
2
pembrolizumab
IBA
06/2022 - 04/2021
2
Tumor Biomarkers (Tumor Markers)
IBA
10/2021 - 10/2015
2
N-acetyltalosaminuronic acid (NAT)
IBA
10/2021 - 01/2018
2
B7-H1 Antigen
IBA
04/2021 - 03/2018
2
Indocyanine Green (Cardio-Green)
FDA Link
Generic
09/2018 - 06/2016
2
Cadherins (E-Cadherin)
IBA
09/2017 - 03/2012
2
Antineoplastic Agents (Antineoplastics)
IBA
12/2016 - 06/2013
2
Indicators and Reagents (Reagents)
IBA
10/2015 - 01/2015
2
teleocalcin
IBA
12/2013 - 01/2012
2
Tin
IBA
08/2013 - 10/2007
2
Ligands
IBA
05/2011 - 12/2010
2
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
10/2010 - 06/2008
2
HMW-MAA
IBA
02/2010 - 06/2008
2
Chemokine Receptors
IBA
07/2009 - 11/2007
2
Keratins (Keratin)
IBA
04/2008 - 03/2008
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
07/2023
1
Trinitrotoluene (TNT)
IBA
03/2023
1
Panitumumab (Vectibix)
FDA Link
03/2023
Therapy/Procedure
44
Drug Therapy (Chemotherapy)
03/2024 - 08/2008
30
Gastrectomy
03/2024 - 10/2007
27
Therapeutics
07/2023 - 04/2007
17
Neoadjuvant Therapy
08/2022 - 01/2007
16
Lymph Node Excision (Lymph Node Dissection)
03/2024 - 05/2004
13
Chemoradiotherapy
03/2023 - 03/2011
7
Esophagectomy
10/2023 - 03/2011
6
Adjuvant Chemotherapy
07/2023 - 04/2017
5
Stents
01/2021 - 10/2013
4
Hepatectomy
03/2024 - 01/2020
4
Radiotherapy
03/2023 - 07/2010
3
Immunotherapy
07/2022 - 07/2020
3
Minimally Invasive Surgical Procedures
05/2019 - 02/2013
3
Operative Surgical Procedures
09/2017 - 03/2011
3
Gastric Bypass (Roux-en-Y Gastric Bypass)
12/2016 - 11/2014
2
Ileostomy
01/2023 - 11/2014
2
Colectomy
11/2022 - 04/2020
2
Induction Chemotherapy
02/2019 - 01/2017
2
Combination Drug Therapy (Combination Chemotherapy)
07/2010 - 01/2007
1
Operative Time
08/2023
1
Restorative Proctocolectomy
01/2023